<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR1800014907</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2018-02-17</date_registration>
      <primary_sponsor>The Third Affiliated Hospital of Sun Yat-Sen University</primary_sponsor>
      <public_title>The clinical trial of using umbilical cord mesenchymal stem cell in children with idiopathic pulmonary hemosiderosis</public_title>
      <acronym />
      <scientific_title>The clinical trial of using umbilical cord mesenchymal stem cell in children with idiopathic pulmonary hemosiderosis</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2018-03-01</date_enrolment>
      <type_enrolment />
      <target_size>Experimental group:16;Control group:16;</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=25429</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>Other</phase>
      <hc_freetext>idiopathic pulmonary hemosiderosis</hc_freetext>
      <i_freetext>Experimental group:Transplantation of hUC-MSCs;Control group:None;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Ya-Ting Li</firstname>
        <middlename />
        <lastname />
        <address>Pediatric Intensive Care Unit, Department of Pediatrics, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, Guangdong, China</address>
        <city />
        <country1 />
        <zip>510630</zip>
        <telephone>+86 13533449139</telephone>
        <email>amy_lyt109@163.com</email>
        <affiliation>The Third Affiliated Hospital of Sun Yat-Sen University</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Ya-Ting Li</firstname>
        <middlename />
        <lastname />
        <address>Pediatric Intensive Care Unit, Department of Pediatrics, The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, Guangdong, China</address>
        <city />
        <country1 />
        <zip>510630</zip>
        <telephone>+86 13533449139</telephone>
        <email>amy_lyt109@163.com</email>
        <affiliation>The Third Affiliated Hospital of Sun Yat-Sen University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. aged from 5-18 years old; 
2. conforms to the IPH diagnostic criteria; 
3. parents or guardians agree to treat and sign written informed consent.</inclusion_criteria>
      <agemin>5</agemin>
      <agemax>18</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. combined with severe underlying diseases, such as systemic systemic malignancies, heart failure, liver and renal failure, immunodeficiency, severe infectious diseases, and other indications for emergency operation after lung transplantation;           
2. patients with other pulmonary diseases;           
3. who had previously participated in the clinical trials of stem cell therapy;            
4. researchers think it is not appropriate to take part in other situations in the study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Episodes of annual pulmonary hemorrhage;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Incidence of adverse reactions;serum iron metabolism;T lymphocyte subset;Pulmonary function tests;sputum induction test;plasma inflammatory factors test;Number of circulating fibroblasts;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The Third Affiliated Hospital of Sun Yat-Sen University, Clinical Research Program</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-12-07</approval_date>
        <contact_name>Chang Liu</contact_name>
        <contact_address>The Third Affiliated Hospital of Sun Yat-Sen University, 600 Tianhe Road, Guangzhou, Guangdong, China</contact_address>
        <contact_phone>+86 020-85252276</contact_phone>
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>